Clinical Trial: Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Energy Intake
Study Type: INTERVENTIONAL
Official Title: Assessment of Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one in Healthy Volunteers Using a Microtracer Approach
Brief Summary:
Worldwide almost 40% of the adult population is overweight (including >10% obese), and more than 350 million children (up to the age of 19) are overweight.Overweight and obesity are significant problems and important risk factors for several lifestyle-related diseases, such as cardiovascular disease, certain cancers, non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D).Excessive consumption of glucose/sucrose is a major contributor to overweight and obesity.Alternative, low-calorie…
Read more